|
ACLY expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.602600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.661400E-01 |
| Normal-vs-Stage2 |
5.272600E-01 |
| Normal-vs-Stage3 |
3.784400E-02 |
| Normal-vs-Stage4 |
4.849900E-02 |
| Stage1-vs-Stage2 |
2.654200E-01 |
| Stage1-vs-Stage3 |
5.922100E-02 |
| Stage1-vs-Stage4 |
1.167360E-01 |
| Stage2-vs-Stage3 |
2.529600E-02 |
| Stage2-vs-Stage4 |
3.095500E-02 |
| Stage3-vs-Stage4 |
9.203800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.751830E-01 |
| Normal-vs-AfricanAmerican |
9.725000E-01 |
| Normal-vs-Asian |
6.071200E-01 |
| Caucasian-vs-AfricanAmerican |
4.400600E-01 |
| Caucasian-vs-Asian |
7.000600E-01 |
| AfricanAmerican-vs-Asian |
6.852600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.476400E-02 |
| Normal-vs-Female |
5.118600E-01 |
| Male-vs-Female |
8.970100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.119800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.328820E-01 |
| Normal-vs-Age(61-80Yrs) |
1.279980E-01 |
| Normal-vs-Age(81-100Yrs) |
9.251200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.670160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.775450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.454000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.859800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.250400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.485400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.353800E-02 |
| Classical-VS-Follicular |
3.314800E-01 |
| Classical-VS-Other |
8.287800E-02 |
| Classical-VS-Normal |
8.339200E-01 |
| Tall-VS-Follicular |
2.359600E-01 |
| Tall-VS-Other |
4.607200E-01 |
| Tall-VS-Normal |
2.776300E-02 |
| Follicular-VS-Other |
2.065800E-01 |
| Follicular-VS-Normal |
3.556400E-01 |
| Other-VS-Normal |
2.847600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.619600E-01 |
| Normal-vs-N1 |
3.785700E-02 |
| N0-vs-N1 |
1.559400E-01 |
|
|
